Global University Venturing

Claudia Pingue, former Politecnico di Milano tech transfer manager, has taken on a leadership role at CDP's $177m spinout investment fund.

Eli Lilly is to exit the genetic sequencing system provider Readcoor in a cash-and-share acquisition by 10x Genomics. This is one of the relatively few exits we have seen in this space over the past decade.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Medical transcription technology provider Abridge has emerged from stealth with seed and series A funding.

Nanopareil employs nanofibre membranes to separate chemical compounds for the purposes of purifying biopharmaceutical candidates.

Five-year commercialisation activity at the university is on the rise in terms of patents, inventions and licensing revenue.

University endowment-backed Will Ventures aims to unlock sports-related innovation across markets such as fitness, media and gaming.

UC Investments has backed cancer cell therapy developer A2 Biotherapeutics, bringing the company's total funding to $136m.

University of Wyoming-backed Momentus is set to merge with SPAC Stable Road Acquisition in a deal that values the space infrastructure company at $1.2bn.

Kidney disease-focused drug developer Walden was co-founded by faculty members of Rush University and Harvard University earlier this year.

Oxford's spinout portfolio raised a record-breaking $1.1bn during the past fiscal year and is now 204-companies strong.